Artificial intelligence beyond the emergency: the ALFABETO solution

Artificial intelligence beyond the emergency: the ALFABETO solution
Event Info
December 15, 2020
4:00 PM - 4:45 PM CET

ALFABETO - All faster better together

The rising number of Covid-19 cases, in the second phase, is worrying due to the progressive increase in deaths and the growing pressure on the hospital network. The current trend of the pandemic requires the activation of all the healthcare sector players. The importance of detecting SARS-CoV-2 early and treating it correctly is very clear and, being the first line of care for citizens, community medicine plays a vital role. As far as community medicine is concerned, there is little evidence of what can be done to improve the outcome of the disease in its different phases, while there is a better understanding of what should not be done. 

The medical association has recently produced a handbook for the treatment of non-hospitalised SARS-CoV-2 patients, which has been approved both at the regional level and by the National Technical and Scientific Committee. The aim of these guidelines is to standardise the level of community treatment and care when it comes to drug administration, oxygen therapy and homecare services, highlighting the appropriate timings for the different phases of the disease and the risk thresholds that instead determine the need for hospitalisation.

However, the approved guidelines for the home treatment of suspected and confirmed Covid patients and the commitment and efforts of the already scarce number of doctors on the front line may not be enough to manage high number of the Covid patients who are at home.

The most advanced technology can give concrete, immediate and practical help. How? Based on retrospective data from the first phase of the pandemic, ALFABETO has proven to be a tool that can offer real, tangible help for hospitals, physicians, general practitioners and patients.

Why take part?

In the round table we will tell you how ALFABETO offers a valuable contribution to the following processes: 

  • Evidence interpretation;
  • SARS-CoV-2 patients classification;
  • Initial approach to patients with SARS-CoV-2 infection-like symptoms;
  • Further diagnostics for patients with confirmed infections or high suspicion despite testing negative.

These aspects will be discussed by the members of the ALFABETO Scientific Board, namely: 

  • Bruno Raffaele, Director Infectious Diseases Unit of Fondazione IRCCS Policlinico San Matteo, Professor of Infectious Diseases of University of Pavia;
  • Perlini Stefano, Director Emergency Medicine Unit of Fondazione IRCCS Policlinico San Matteo, Professor of Internal Medicine of University of Pavia;
  • Preda Lorenzo, Director Institute of Radiology of Fondazione IRCCS Policlinico San Matteo, Professor of Radiology and Director Emergency Medicine Postgraduate Training Program of University of Pavia;
  • Poggi PaoloHead of Center for Diagnostic Imaging - ICS Maugeri IRCCS.

Reply Webinars

Reply's Webinars series covers all industries and spans the latest innovation trends.
View all upcoming webinars